Li et al. showed that leptin promoted the IL-18 expression and secretion in TAMs via NF-κB/NF-κB1 and breast cancer cells via PI3K-AKT/ATF-2 pathway, ultimately leading to breast cancer cell migration and invasion [123]. Here, LEP is linked to breast carcinoma.